Dr. Zhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2017 - 2020- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2014 - 2017
Case Western Reserve University School of MedicineClass of 2014
Certifications & Licensure
CA State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study Start of enrollment: 2021 Nov 18
Publications & Presentations
PubMed
- 62 citationsMyocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors.Sarah Waliany, Joel W. Neal, Sunil Reddy, Heather A. Wakelee, Sumit A. Shah
JACC. Cardiooncology. 2021-03-01 - 9 citationsCoronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.Joseph Nowatzke, Paul Guedeney, Nicholas Palaskas, Lorenz Lehmann, Stephane Ederhy
European Journal of Cancer. 2022-12-01 - 43 citationsIdentification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.Han Zhu, Francisco X Galdos, Daniel Lee, Sarah Waliany, Yuhsin Vivian Huang
Circulation. 2022-07-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
